The FDA approved Journavx (suzetrigine) 50 mg oral tablets, a first-in-class non-opioid analgesic to treat moderate to severe acute pain in adults.
#stockmarket #breaking
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain – FDA.gov
